Arylmethoxy Isoindoline Derivatives and Compositions Comprising and Methods of Using the Same
申请人:Man Hon-Wah
公开号:US20110196150A1
公开(公告)日:2011-08-11
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
申请人:Celgene Corporation
公开号:US20180037567A1
公开(公告)日:2018-02-08
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
申请人:Celgene Corporation
公开号:US10189814B2
公开(公告)日:2019-01-29
Provided are 4′-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.